Overview
Shervin Taslimi practices in Kingston, Canada. Mr. Taslimi is rated as an Experienced expert by MediFind in the treatment of Cerebral Cavernous Malformation. His top areas of expertise are Epidural Abscess, Epidural Hematoma, Glioblastoma, Astrocytoma, and Carotid Artery Surgery.
His clinical research consists of co-authoring 48 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Cerebral Cavernous Malformation.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Epidural AbscessMr. Taslimi isDistinguished. Learn about Epidural Abscess.
- Advanced
- AstrocytomaMr. Taslimi isAdvanced. Learn about Astrocytoma.
- Epidural HematomaMr. Taslimi isAdvanced. Learn about Epidural Hematoma.
- GlioblastomaMr. Taslimi isAdvanced. Learn about Glioblastoma.
- Experienced
- Acoustic NeuromaMr. Taslimi isExperienced. Learn about Acoustic Neuroma.
- Brain AbscessMr. Taslimi isExperienced. Learn about Brain Abscess.
- Brain TumorMr. Taslimi isExperienced. Learn about Brain Tumor.
- Carotid Artery SurgeryMr. Taslimi isExperienced. Learn about Carotid Artery Surgery.
- Cerebral Cavernous MalformationMr. Taslimi isExperienced. Learn about Cerebral Cavernous Malformation.
- Chronic Myelomonocytic Leukemia (CMML)Mr. Taslimi isExperienced. Learn about Chronic Myelomonocytic Leukemia (CMML).